Same file, different rules. Each brief states a view and why. Briefs are written in isolation so one loud narrative cannot drag the room. The clerk reads them only after they exist. Never “you should buy.” There is no buy button.
Cathie Wood
Disruptive Innovation Lead
Isolated
View
Constructive — the work is worth continuing, not an order. On HDB, I care whether the decade capital flow still funds this vehicle — revenue YoY 15.2%, revenue $25.6B. Region: India.
Why
Why: Horizon is 5+ years; reject 12-month price targets as the main frame. If the industry is not on the decade map, I pass without a speech. On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken..
Analysis
Question: “Research HDB as a US-listed emerging-market name.”.
Business dig: HDB must still sit inside a funded decade theme — not a tourist ticker. On file: revenue $25.6B; revenue YoY 15.2%.
Method: Horizon is 5+ years; reject 12-month price targets as the main frame. Second rule: Map the name to ARK-style platforms: AI, robotics, energy storage, multiomics, fintech rails.
Variant view: the tape often prices the theme; this seat prices whether HDB is the vehicle.
Underwrite frame: Worth further homework. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: the era is right and the vehicle is wrong — or the era has already been bid. EM-specific: Funding cost or asset quality after the merger stays broken.
Looks at
revenue CAGR vs category S-curve
On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
This seat flips if: Funding cost or asset quality after the merger stays broken..
Philippe Laffont
Tech Commercialization Validator
Isolated
View
Constructive — the work is worth continuing, not an order. On HDB, I care whether the decade capital flow still funds this vehicle — revenue YoY 15.2%, revenue $25.6B. Region: India.
Why
Why: A trend is only investable once it hits a commercialization inflection: revenue, not demos. If the industry is not on the decade map, I pass without a speech. On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken..
Analysis
Question: “Research HDB as a US-listed emerging-market name.”.
Business dig: HDB must still sit inside a funded decade theme — not a tourist ticker. On file: revenue $25.6B; revenue YoY 15.2%.
Method: A trend is only investable once it hits a commercialization inflection: revenue, not demos. Second rule: Demand proof of unit economics: contribution margin, payback, net retention.
Variant view: the tape often prices the theme; this seat prices whether HDB is the vehicle.
Underwrite frame: Worth further homework. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: the era is right and the vehicle is wrong — or the era has already been bid. EM-specific: Funding cost or asset quality after the merger stays broken.
Looks at
YoY revenue inflection
On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
This seat flips if: Funding cost or asset quality after the merger stays broken..
Ray Dalio
Debt Cycle Architect
Isolated
View
Cautious — the file is open, the bar is not cleared. HDB sits on the thermometer before any multiple debate — Late Expansion at 62. Region: India.
Why
Why: cycle first. The short-term debt cycle is hot; long-term debt is still high. This is not crisis pricing. A hot reading is not a ticket. On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken..
Analysis
Question: “Research HDB as a US-listed emerging-market name.”.
Regime first: Late Expansion, thermometer 62. The short-term debt cycle is hot; long-term debt is still high. This is not crisis pricing.
On HDB: On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
I will not time an entry from this chair. I will say whether the print smells mid-cycle or peak.
Underwrite frame: Worth further homework. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: treating a regime note as a timing ticket. EM-specific: Funding cost or asset quality after the merger stays broken.
Looks at
policy rate vs inflation
On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
This seat flips if: Funding cost or asset quality after the merger stays broken..
Howard Marks
Market Pendulum Assessor
Isolated
View
Cautious — the file is open, the bar is not cleared. HDB sits on the thermometer before any multiple debate — Late Expansion at 62. Region: India.
Why
Why: cycle first. The short-term debt cycle is hot; long-term debt is still high. This is not crisis pricing. A hot reading is not a ticket. On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken..
Analysis
Question: “Research HDB as a US-listed emerging-market name.”.
Regime first: Late Expansion, thermometer 62. The short-term debt cycle is hot; long-term debt is still high. This is not crisis pricing.
On HDB: On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
I will not time an entry from this chair. I will say whether the print smells mid-cycle or peak.
Underwrite frame: Worth further homework. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: treating a regime note as a timing ticket. EM-specific: Funding cost or asset quality after the merger stays broken.
Looks at
credit spreads vs history
On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
This seat flips if: Funding cost or asset quality after the merger stays broken..
John Templeton
Sentiment Extremes Detector
Isolated
View
Cautious — the file is open, the bar is not cleared. HDB sits on the thermometer before any multiple debate — Late Expansion at 62. Region: India.
Why
Why: cycle first. The short-term debt cycle is hot; long-term debt is still high. This is not crisis pricing. A hot reading is not a ticket. On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken..
Analysis
Question: “Research HDB as a US-listed emerging-market name.”.
Regime first: Late Expansion, thermometer 62. The short-term debt cycle is hot; long-term debt is still high. This is not crisis pricing.
On HDB: On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
I will not time an entry from this chair. I will say whether the print smells mid-cycle or peak.
Underwrite frame: Worth further homework. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: treating a regime note as a timing ticket. EM-specific: Funding cost or asset quality after the merger stays broken.
Looks at
drawdown from peak
On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
This seat flips if: Funding cost or asset quality after the merger stays broken..
George Soros
Reflexivity Tester
Isolated
View
Cautious — the file is open, the bar is not cleared. HDB sits on the thermometer before any multiple debate — Late Expansion at 62. Region: India.
Why
Why: cycle first. The short-term debt cycle is hot; long-term debt is still high. This is not crisis pricing. A hot reading is not a ticket. On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken..
Analysis
Question: “Research HDB as a US-listed emerging-market name.”.
Regime first: Late Expansion, thermometer 62. The short-term debt cycle is hot; long-term debt is still high. This is not crisis pricing.
On HDB: On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
I will not time an entry from this chair. I will say whether the print smells mid-cycle or peak.
Underwrite frame: Worth further homework. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: treating a regime note as a timing ticket. EM-specific: Funding cost or asset quality after the merger stays broken.
Looks at
Reflexivity Tester
On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
This seat flips if: Funding cost or asset quality after the merger stays broken..
John Paulson
Credit Quality & Systemic Risk Monitor
Isolated
View
Cautious — the file is open, the bar is not cleared. HDB sits on the thermometer before any multiple debate — Late Expansion at 62. Region: India.
Why
Why: cycle first. The short-term debt cycle is hot; long-term debt is still high. This is not crisis pricing. A hot reading is not a ticket. On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken..
Analysis
Question: “Research HDB as a US-listed emerging-market name.”.
Regime first: Late Expansion, thermometer 62. The short-term debt cycle is hot; long-term debt is still high. This is not crisis pricing.
On HDB: On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
I will not time an entry from this chair. I will say whether the print smells mid-cycle or peak.
Underwrite frame: Worth further homework. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: treating a regime note as a timing ticket. EM-specific: Funding cost or asset quality after the merger stays broken.
Looks at
Credit Quality & Systemic Risk Monitor
On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
This seat flips if: Funding cost or asset quality after the merger stays broken..
Paul Tudor Jones
Macro Cycle Inflection Confirmer
Isolated
View
Cautious — the file is open, the bar is not cleared. HDB sits on the thermometer before any multiple debate — Late Expansion at 62. Region: India.
Why
Why: cycle first. The short-term debt cycle is hot; long-term debt is still high. This is not crisis pricing. A hot reading is not a ticket. On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken..
Analysis
Question: “Research HDB as a US-listed emerging-market name.”.
Regime first: Late Expansion, thermometer 62. The short-term debt cycle is hot; long-term debt is still high. This is not crisis pricing.
On HDB: On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
I will not time an entry from this chair. I will say whether the print smells mid-cycle or peak.
Underwrite frame: Worth further homework. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: treating a regime note as a timing ticket. EM-specific: Funding cost or asset quality after the merger stays broken.
Looks at
Macro Cycle Inflection Confirmer
On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
This seat flips if: Funding cost or asset quality after the merger stays broken..
Benjamin Graham
Margin of Safety Guardian
Isolated
View
Cautious — the file is open, the bar is not cleared. Owner test on HDB: P/E 21.0, P/B 1.86, ROE 8.8%, net income $7.9B. Region: India.
Why
Why: Teacherly, quantitative, unsentimental. I want a business I would own in full. On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken..
Analysis
Question: “Research HDB as a US-listed emerging-market name.”.
Owner earnings lens on HDB. Teacherly, quantitative, unsentimental. Hard rule: Margin of safety: pay well below a conservative appraisal of intrinsic value (classically ~2/3).
Numbers on file: P/E 21.0; P/B 1.86; ROE 8.8%; net income $7.9B; revenue YoY 15.2%. On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
A low multiple that needs a hero story is not a margin of safety. A rich multiple with durable ROE can still be a business — but then price is the risk.
Underwrite frame: Worth further homework. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: a multiple that looks cheap because earnings are peak, or a quality story that needs the multiple to re-rate. EM-specific: Funding cost or asset quality after the merger stays broken.
Looks at
P/B
On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
This seat flips if: Funding cost or asset quality after the merger stays broken..
Warren Buffett
Moat & Management Final Review
Isolated
View
Cautious — the file is open, the bar is not cleared. Owner test on HDB: P/E 21.0, P/B 1.86, ROE 8.8%, net income $7.9B. Region: India.
Why
Why: Plain Midwest English, folksy metaphors, long-horizon. I want a business I would own in full. On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken..
Analysis
Question: “Research HDB as a US-listed emerging-market name.”.
Owner earnings lens on HDB. Plain Midwest English, folksy metaphors, long-horizon. Hard rule: Circle of competence: if the business cannot be explained simply, pass.
Numbers on file: P/E 21.0; P/B 1.86; ROE 8.8%; net income $7.9B; revenue YoY 15.2%. On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
A low multiple that needs a hero story is not a margin of safety. A rich multiple with durable ROE can still be a business — but then price is the risk.
Underwrite frame: Worth further homework. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: a multiple that looks cheap because earnings are peak, or a quality story that needs the multiple to re-rate. EM-specific: Funding cost or asset quality after the merger stays broken.
Looks at
ROIC / ROE durability
On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
This seat flips if: Funding cost or asset quality after the merger stays broken..
Seth Klarman
Distressed & Special Situations
Isolated
View
Cautious — the file is open, the bar is not cleared. Owner test on HDB: P/E 21.0, P/B 1.86, ROE 8.8%, net income $7.9B. Region: India.
Why
Why: Cautious, cash-heavy, academic-practitioner. I want a business I would own in full. On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken..
Analysis
Question: “Research HDB as a US-listed emerging-market name.”.
Owner earnings lens on HDB. Cautious, cash-heavy, academic-practitioner. Hard rule: Margin of safety is a philosophy, not a slogan — downside first.
Numbers on file: P/E 21.0; P/B 1.86; ROE 8.8%; net income $7.9B; revenue YoY 15.2%. On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
A low multiple that needs a hero story is not a margin of safety. A rich multiple with durable ROE can still be a business — but then price is the risk.
Underwrite frame: Worth further homework. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: a multiple that looks cheap because earnings are peak, or a quality story that needs the multiple to re-rate. EM-specific: Funding cost or asset quality after the merger stays broken.
Looks at
downside to liquidation or conservative FCF
On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
This seat flips if: Funding cost or asset quality after the merger stays broken..
Chuck Akre
Compounding Machine Identifier
Isolated
View
Cautious — the file is open, the bar is not cleared. Owner test on HDB: P/E 21.0, P/B 1.86, ROE 8.8%, net income $7.9B. Region: India.
Why
Why: Contemporary. I want a business I would own in full. On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken..
Analysis
Question: “Research HDB as a US-listed emerging-market name.”.
Owner earnings lens on HDB. Contemporary. Hard rule: Three-legged stool: business model / reinvestment / management. ~13%+ compounded..
Numbers on file: P/E 21.0; P/B 1.86; ROE 8.8%; net income $7.9B; revenue YoY 15.2%. On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
A low multiple that needs a hero story is not a margin of safety. A rich multiple with durable ROE can still be a business — but then price is the risk.
Underwrite frame: Worth further homework. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: a multiple that looks cheap because earnings are peak, or a quality story that needs the multiple to re-rate. EM-specific: Funding cost or asset quality after the merger stays broken.
Looks at
Compounding Machine Identifier
On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
This seat flips if: Funding cost or asset quality after the merger stays broken..
Duan Yongping
Business Model Clarity Checker
Isolated
View
Cautious — the file is open, the bar is not cleared. Owner test on HDB: P/E 21.0, P/B 1.86, ROE 8.8%, net income $7.9B. Region: India.
Why
Why: Plain Chinese-internet elder-brother tone: 本分, 买股票就是买公司. I want a business I would own in full. On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken..
Analysis
Question: “Research HDB as a US-listed emerging-market name.”.
Owner earnings lens on HDB. Plain Chinese-internet elder-brother tone: 本分, 买股票就是买公司. Hard rule: Buying a stock is buying a piece of a company — if you would not buy the whole business, pass.
Numbers on file: P/E 21.0; P/B 1.86; ROE 8.8%; net income $7.9B; revenue YoY 15.2%. On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
A low multiple that needs a hero story is not a margin of safety. A rich multiple with durable ROE can still be a business — but then price is the risk.
Underwrite frame: Worth further homework. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: a multiple that looks cheap because earnings are peak, or a quality story that needs the multiple to re-rate. EM-specific: Funding cost or asset quality after the merger stays broken.
Looks at
business model in one sentence
On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
This seat flips if: Funding cost or asset quality after the merger stays broken..
Li Lu
Circle of Competence + Civilization Cycle
Isolated
View
Cautious — the file is open, the bar is not cleared. Owner test on HDB: P/E 21.0, P/B 1.86, ROE 8.8%, net income $7.9B. Region: India.
Why
Why: Contemporary. I want a business I would own in full. On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken..
Analysis
Question: “Research HDB as a US-listed emerging-market name.”.
Owner earnings lens on HDB. Contemporary. Hard rule: Himalaya Capital. Munger family asset manager. Chinese assets expert..
Numbers on file: P/E 21.0; P/B 1.86; ROE 8.8%; net income $7.9B; revenue YoY 15.2%. On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
A low multiple that needs a hero story is not a margin of safety. A rich multiple with durable ROE can still be a business — but then price is the risk.
Underwrite frame: Worth further homework. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: a multiple that looks cheap because earnings are peak, or a quality story that needs the multiple to re-rate. EM-specific: Funding cost or asset quality after the merger stays broken.
Looks at
Circle of Competence + Civilization Cycle
On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
This seat flips if: Funding cost or asset quality after the merger stays broken..
Peter Lynch
Ten-Bagger Hunter
Isolated
View
Constructive — the work is worth continuing, not an order. Classify HDB before cheering growth. revenue YoY 15.2%. P/E 21.0. Region: India.
Why
Why: Six-category company classification system.. Unclassified growth is a narrative. On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken..
Analysis
Question: “Research HDB as a US-listed emerging-market name.”.
Classify before multiple. Six-category company classification system..
revenue YoY 15.2%. P/E 21.0. revenue $25.6B. On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
Fast growth with no category is how you buy a story. Stalwart growth with a broken category is how you overstay.
Underwrite frame: Worth further homework. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: mis-classification — a cyclical labeled a compounder. EM-specific: Funding cost or asset quality after the merger stays broken.
Looks at
EPS growth
On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
This seat flips if: Funding cost or asset quality after the merger stays broken..
Bill Ackman
Quality Giant + Activist Catalyst
Isolated
View
Constructive — the work is worth continuing, not an order. Classify HDB before cheering growth. revenue YoY 15.2%. P/E 21.0. Region: India.
Why
Why: Made $2.6B shorting COVID in 2020; famous Herbalife battle with Icahn.. Unclassified growth is a narrative. On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken..
Analysis
Question: “Research HDB as a US-listed emerging-market name.”.
Classify before multiple. Made $2.6B shorting COVID in 2020; famous Herbalife battle with Icahn..
revenue YoY 15.2%. P/E 21.0. revenue $25.6B. On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
Fast growth with no category is how you buy a story. Stalwart growth with a broken category is how you overstay.
Underwrite frame: Worth further homework. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: mis-classification — a cyclical labeled a compounder. EM-specific: Funding cost or asset quality after the merger stays broken.
Looks at
Quality Giant + Activist Catalyst
On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
This seat flips if: Funding cost or asset quality after the merger stays broken..
Joel Greenblatt
Magic Formula + Special Situations
Isolated
View
Constructive — the work is worth continuing, not an order. Classify HDB before cheering growth. revenue YoY 15.2%. P/E 21.0. Region: India.
Why
Why: Author of The Little Book That Beats the Market.. Unclassified growth is a narrative. On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken..
Analysis
Question: “Research HDB as a US-listed emerging-market name.”.
Classify before multiple. Author of The Little Book That Beats the Market..
revenue YoY 15.2%. P/E 21.0. revenue $25.6B. On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
Fast growth with no category is how you buy a story. Stalwart growth with a broken category is how you overstay.
Underwrite frame: Worth further homework. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: mis-classification — a cyclical labeled a compounder. EM-specific: Funding cost or asset quality after the merger stays broken.
Looks at
EBIT/EV
On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
This seat flips if: Funding cost or asset quality after the merger stays broken..
David Einhorn
Financial Statement Quality Inquisitor
Isolated
View
Cautious — the file is open, the bar is not cleared. Invert HDB first. What has to be false for the bull to die? Region: India.
Why
Why: kill-shot seat. Red team only: interrogate, do not pitch a long Footnotes beat stories. On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken..
Analysis
Question: “Research HDB as a US-listed emerging-market name.”.
Invert HDB. Red team only: interrogate, do not pitch a long.
On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
Name what must be true for the bull: earnings quality, leverage (0.76), and whether footnotes hide the cycle. If I cannot name the kill path, I am not doing the job.
Underwrite frame: Worth further homework. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: the fraud/cycle path is in the footnotes and the bull case ignores it. EM-specific: Funding cost or asset quality after the merger stays broken.
Looks at
receivables vs revenue
On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
This seat flips if: Funding cost or asset quality after the merger stays broken..
Michael Burry
Extreme Contrarian: Hidden Assumptions
Isolated
View
Cautious — the file is open, the bar is not cleared. Invert HDB first. What has to be false for the bull to die? Region: India.
Why
Why: kill-shot seat. Red team: dismantle the valuation model's hidden assumptions Footnotes beat stories. On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken..
Analysis
Question: “Research HDB as a US-listed emerging-market name.”.
Invert HDB. Red team: dismantle the valuation model's hidden assumptions.
On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
Name what must be true for the bull: earnings quality, leverage (0.76), and whether footnotes hide the cycle. If I cannot name the kill path, I am not doing the job.
Underwrite frame: Worth further homework. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: the fraud/cycle path is in the footnotes and the bull case ignores it. EM-specific: Funding cost or asset quality after the merger stays broken.
Looks at
embedded growth rate in the multiple
On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
This seat flips if: Funding cost or asset quality after the merger stays broken..
Carl Icahn
Governance & Self-Dealing Interrogator
Isolated
View
Cautious — the file is open, the bar is not cleared. Invert HDB first. What has to be false for the bull to die? Region: India.
Why
Why: kill-shot seat. Icahn Enterprises. Corporate governance and self-dealing scrutiny. Footnotes beat stories. On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken..
Analysis
Question: “Research HDB as a US-listed emerging-market name.”.
Invert HDB. Icahn Enterprises. Corporate governance and self-dealing scrutiny..
On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
Name what must be true for the bull: earnings quality, leverage (0.76), and whether footnotes hide the cycle. If I cannot name the kill path, I am not doing the job.
Underwrite frame: Worth further homework. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: the fraud/cycle path is in the footnotes and the bull case ignores it. EM-specific: Funding cost or asset quality after the merger stays broken.
Looks at
Governance & Self-Dealing Interrogator
On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
This seat flips if: Funding cost or asset quality after the merger stays broken..
Dan Loeb
Narrative & Catalyst Authenticity Checker
Isolated
View
Cautious — the file is open, the bar is not cleared. Invert HDB first. What has to be false for the bull to die? Region: India.
Why
Why: kill-shot seat. Third Point. Sharp shareholder letters + event-driven analysis. Footnotes beat stories. On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken..
Analysis
Question: “Research HDB as a US-listed emerging-market name.”.
Invert HDB. Third Point. Sharp shareholder letters + event-driven analysis..
On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
Name what must be true for the bull: earnings quality, leverage (0.76), and whether footnotes hide the cycle. If I cannot name the kill path, I am not doing the job.
Underwrite frame: Worth further homework. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: the fraud/cycle path is in the footnotes and the bull case ignores it. EM-specific: Funding cost or asset quality after the merger stays broken.
Looks at
Narrative & Catalyst Authenticity Checker
On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
This seat flips if: Funding cost or asset quality after the merger stays broken..
Paul Singer
Tail Risk & Legal/Contract Vulnerability
Isolated
View
Cautious — the file is open, the bar is not cleared. Invert HDB first. What has to be false for the bull to die? Region: India.
Why
Why: kill-shot seat. Elliott Management. Activist and distressed debt. Tail risk and legal vulnerability. Footnotes beat stories. On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken..
Analysis
Question: “Research HDB as a US-listed emerging-market name.”.
Invert HDB. Elliott Management. Activist and distressed debt. Tail risk and legal vulnerability..
On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
Name what must be true for the bull: earnings quality, leverage (0.76), and whether footnotes hide the cycle. If I cannot name the kill path, I am not doing the job.
Underwrite frame: Worth further homework. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: the fraud/cycle path is in the footnotes and the bull case ignores it. EM-specific: Funding cost or asset quality after the merger stays broken.
Looks at
Tail Risk & Legal/Contract Vulnerability
On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
This seat flips if: Funding cost or asset quality after the merger stays broken..
Michael Steinhardt
Consensus Divergence Tester
Isolated
View
Cautious — the file is open, the bar is not cleared. Invert HDB first. What has to be false for the bull to die? Region: India.
Why
Why: kill-shot seat. Hedge fund pioneer. 30-year ~24% annualized. Where does this thesis diverge from consensus? Footnotes beat stories. On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken..
Analysis
Question: “Research HDB as a US-listed emerging-market name.”.
Invert HDB. Hedge fund pioneer. 30-year ~24% annualized. Where does this thesis diverge from consensus?.
On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
Name what must be true for the bull: earnings quality, leverage (0.76), and whether footnotes hide the cycle. If I cannot name the kill path, I am not doing the job.
Underwrite frame: Worth further homework. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: the fraud/cycle path is in the footnotes and the bull case ignores it. EM-specific: Funding cost or asset quality after the merger stays broken.
Looks at
Consensus Divergence Tester
On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
This seat flips if: Funding cost or asset quality after the merger stays broken..
Stanley Druckenmiller
Conviction Concentration Stress Test
Isolated
View
Cautious — the file is open, the bar is not cleared. Invert HDB first. What has to be false for the bull to die? Region: India.
Why
Why: kill-shot seat. Duquesne Capital. 30+ year ~30% annualized. "If you had one shot, would you bet big?" Footnotes beat stories. On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken..
Analysis
Question: “Research HDB as a US-listed emerging-market name.”.
Invert HDB. Duquesne Capital. 30+ year ~30% annualized. "If you had one shot, would you bet big?".
On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
Name what must be true for the bull: earnings quality, leverage (0.76), and whether footnotes hide the cycle. If I cannot name the kill path, I am not doing the job.
Underwrite frame: Worth further homework. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: the fraud/cycle path is in the footnotes and the bull case ignores it. EM-specific: Funding cost or asset quality after the merger stays broken.
Looks at
Conviction Concentration Stress Test
On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
This seat flips if: Funding cost or asset quality after the merger stays broken..
Charlie Munger
Inversion Thinking Arbiter
Isolated
View
Cautious — the file is open, the bar is not cleared. Invert HDB first. What has to be false for the bull to die? Region: India.
Why
Why: kill-shot seat. Invert: how would this thesis get killed? List the kill-shots before the romance Footnotes beat stories. On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken..
Analysis
Question: “Research HDB as a US-listed emerging-market name.”.
Invert HDB. Invert: how would this thesis get killed? List the kill-shots before the romance.
On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
Name what must be true for the bull: earnings quality, leverage (0.76), and whether footnotes hide the cycle. If I cannot name the kill path, I am not doing the job.
Underwrite frame: Worth further homework. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: the fraud/cycle path is in the footnotes and the bull case ignores it. EM-specific: Funding cost or asset quality after the merger stays broken.
Looks at
incentive structure
On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
This seat flips if: Funding cost or asset quality after the merger stays broken..
William O'Neil
CANSLIM Entry Point
Isolated
View
Constructive — the work is worth continuing, not an order. No trigger, no implied entry on HDB — quality seats do not move this pencil. Region: India.
Why
Why: without a stage/breakout/turtle trigger, a good business is still not an entry. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken..
Analysis
Question: “Research HDB as a US-listed emerging-market name.”.
Trigger or nothing. On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
Stage / breakout / turtle — pick the method this seat uses. A constructive quality seat elsewhere does not create an entry here.
Underwrite frame: Worth further homework. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: entering because the committee liked the business. EM-specific: Funding cost or asset quality after the merger stays broken.
Looks at
quarterly EPS acceleration
On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
This seat flips if: Funding cost or asset quality after the merger stays broken..
Mark Minervini
SEPA Stage-2 Confirmation
Isolated
View
Constructive — the work is worth continuing, not an order. No trigger, no implied entry on HDB — quality seats do not move this pencil. Region: India.
Why
Why: without a stage/breakout/turtle trigger, a good business is still not an entry. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken..
Analysis
Question: “Research HDB as a US-listed emerging-market name.”.
Trigger or nothing. On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
Stage / breakout / turtle — pick the method this seat uses. A constructive quality seat elsewhere does not create an entry here.
Underwrite frame: Worth further homework. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: entering because the committee liked the business. EM-specific: Funding cost or asset quality after the merger stays broken.
Looks at
SEPA Stage-2 Confirmation
On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
This seat flips if: Funding cost or asset quality after the merger stays broken..
Steve Cohen
Short-Term Signal & Tape Reading
Isolated
View
Constructive — the work is worth continuing, not an order. No trigger, no implied entry on HDB — quality seats do not move this pencil. Region: India.
Why
Why: without a stage/breakout/turtle trigger, a good business is still not an entry. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken..
Analysis
Question: “Research HDB as a US-listed emerging-market name.”.
Trigger or nothing. On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
Stage / breakout / turtle — pick the method this seat uses. A constructive quality seat elsewhere does not create an entry here.
Underwrite frame: Worth further homework. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: entering because the committee liked the business. EM-specific: Funding cost or asset quality after the merger stays broken.
Looks at
Short-Term Signal & Tape Reading
On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
This seat flips if: Funding cost or asset quality after the merger stays broken..
Ed Thorp
Kelly Criterion Position Sizing
Isolated
View
Cautious — the file is open, the bar is not cleared. HDB is a distribution. P/E 21.0; P/B 1.86. Thin sample → smaller size. Region: India.
Why
Why: if edge is not measurable, Kelly ceiling collapses. On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken..
Analysis
Question: “Research HDB as a US-listed emerging-market name.”.
HDB is a return distribution, not a feeling. On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
P/E 21.0; P/B 1.86. If sample is thin or correlations hid risk, size shrinks. Kelly is a ceiling.
Underwrite frame: Worth further homework. EM overlay: India · Private bank. Quality India compounding. Merger integration is a diligence item, not a slogan. Kill-shot unique to this listing: Funding cost or asset quality after the merger stays broken.. Isolated: I am not averaging a country ETF view with this name.
Risks
Main risk: overfitting a short sample or sizing as if variance were known. EM-specific: Funding cost or asset quality after the merger stays broken.
Looks at
whether a statistical edge is even claimed
On file: 20-F FY FY2025; revenue $25.6B; revenue YoY 15.2%; net income $7.9B; ROE 8.8%; LT debt/equity 0.76; P/E 21.0; P/B 1.9; P/S 6.5; price $21.84 cached.
This seat flips if: Funding cost or asset quality after the merger stays broken..
